Product Information

DEXTROAMPH-AMPHET ER 12.5 MG CP is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $8.2652 per EA under NDC 57664095088. Its NADAC has been published 118 times since May 22, 2024.

FDA first approved this application on Sep 27, 2023. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DEA Schedule CII

Strength

3.125; 3.125; 3.125; 3.125 mg/1; mg/1; mg/1; mg/1

NDC

57664095088

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA215997

FDA Approved

9/27/2023

TE Code

AB2

On Market Since

2/1/2024

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation

Price Statistics

The NADAC for DEXTROAMPH-AMPHET ER 12.5 MG CP has been published 118 times since May 22, 2024, and over the history we have for it it has risen 5.1%. The table below summarizes its recorded NADAC range and movement.

Current price$8.2652 per EA
All-time high$8.8437 (Aug 13, 2025)
All-time low$7.8649 (May 22, 2024)
52-week high$8.7921
52-week low$8.0653
Median price$8.3525
Average price$8.3670
Largest weekly change+6.2% (Jun 19, 2024)
Weeks tracked118
Tracking sinceMay 22, 2024

Price History

1W

+2.5%

1M

+2.5%

3M

+1.2%

6M

-1.8%

1Y

-6.0%

3Y

N/A

5Y

N/A

All

+5.1%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of DEXTROAMPH-AMPHET ER 12.5 MG CP?

The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMPH-AMPHET ER 12.5 MG CP, manufactured by Sun Pharmaceutical Industries Inc., is $8.2652 per EA (NDC 57664095088), effective Aug 19, 2026.

How has the price of DEXTROAMPH-AMPHET ER 12.5 MG CP changed over time?

Over the history we have for it, the NADAC for DEXTROAMPH-AMPHET ER 12.5 MG CP has risen 5.1%. It has been tracked across 118 weekly CMS publications since May 22, 2024.

What are the highest and lowest recorded NADAC prices for DEXTROAMPH-AMPHET ER 12.5 MG CP?

Since May 22, 2024, the NADAC for DEXTROAMPH-AMPHET ER 12.5 MG CP has ranged from a low of $7.8649 (May 22, 2024) to a high of $8.8437 (Aug 13, 2025), with a median of $8.3525 per EA.

Are there cheaper alternatives to DEXTROAMPH-AMPHET ER 12.5 MG CP?

No other NADAC-published product currently shares the active ingredient and strength of DEXTROAMPH-AMPHET ER 12.5 MG CP in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures DEXTROAMPH-AMPHET ER 12.5 MG CP?

DEXTROAMPH-AMPHET ER 12.5 MG CP (NDC 57664095088) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.